CONVECTIVE VOLUME, PATIENT ANTHROPOMETRIC CHARACTERISTICS AND RISK OF ALL-CAUSE MORTALITY IN HEMODIAFILTRATION: A COHORT STUDY

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/304f968f5cb98e42446b21dd8e78161e.pdf
CONVECTIVE VOLUME, PATIENT ANTHROPOMETRIC CHARACTERISTICS AND RISK OF ALL-CAUSE MORTALITY IN HEMODIAFILTRATION: A COHORT STUDY

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Krister
Cromm
Krister Cromm krister.cromm@freseniusmedicalcare.com Fresenius Medical Care Global Medical Office Bad Homburg Germany * Charite Center for Patient-Centered Outcomes Research Berlin Germany
Robin W. Vernooij r.w.m.vernooij-2@umcutrecht.nl Utrecht University Universitair Medisch Centrum Utrecht Utrecht Netherlands -
Bernaud J. Canaud canaudbernard@gmail.com University of Montpellier Montpellier France -
Claudia M. Barth claudia.barth@bbraun.com B Braun Avitum AG Melsungen Germany -
Jörgen B. Hegbrant jbahegbrant@gmail.com Lund University Lund Sweden -
Andrew Davenport andrewdavenport@nhs.net University College London London United Kingdom -
Mark Woodward markw@georgeinstitute.org.au The George Institute for Global Health UK Oxford United Kingdom - The George Institute for Global Health Australia Sydney Australia
Michiel L. Bots M.L.Bots@umcutrecht.nl Utrecht University Universitair Medisch Centrum Utrecht Utrecht Netherlands -
Peter J. Blankestijn P.J.Blankestijn@umcutrecht.nl Utrecht University Universitair Medisch Centrum Utrecht Utrecht Netherlands -
Giovanni Strippoli gfmstrippoli@gmail.com University of Bari Department of Precision and Regenerative Medicine and Ionian Area (Dimepre-J) Bari Italy - University of Sydney School of Public Health Sydney Australia
-
-
-
-
-